AGL
Agilon Health, Inc. NYSE$26.94
Mkt Cap $448.8M
52w Low $7.48
17.4% of range
52w High $119.50
50d MA $17.52
200d MA $22.62
P/E (TTM)
-1.2x
EV/EBITDA
-0.4x
P/B
3.9x
Debt/Equity
0.3x
ROE
-83.1%
P/FCF
-2.4x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$17.52
200d MA
$22.62
Avg Volume
322.4K
About
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon hea…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | -6.75 | -11.50 | -70.4% | 12.50 | -1.0% | +19.0% | +17.8% | +23.1% | +13.5% | +39.7% | — |
| Nov 4, 2025 | AMC | -0.18 | -0.27 | -50.0% | 18.11 | +3.0% | +4.0% | -3.8% | -7.9% | -8.9% | -14.6% | — |
| Aug 4, 2025 | AMC | -0.11 | -0.25 | -127.3% | 45.50 | -43.4% | -51.6% | -51.1% | -51.9% | -52.0% | -52.6% | — |
| May 6, 2025 | AMC | -0.01 | 0.03 | +393.0% | 111.50 | +5.6% | -24.0% | -27.8% | -35.2% | -33.4% | -39.5% | — |
| Feb 25, 2025 | AMC | -0.18 | -0.25 | -38.9% | 90.75 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% | — |
| Nov 7, 2024 | AMC | -0.10 | -0.29 | -190.0% | 69.75 | -33.3% | -34.1% | -22.6% | -33.0% | -32.6% | -38.7% | — |
| Aug 6, 2024 | AMC | -0.07 | -0.07 | +0.0% | 155.50 | +0.0% | -9.3% | -10.0% | -11.3% | -14.3% | -10.3% | — |
| May 7, 2024 | AMC | -0.02 | 0.01 | +150.0% | 124.50 | +6.4% | +4.2% | +5.6% | +4.2% | +4.6% | +10.4% | — |
| Feb 27, 2024 | AMC | -0.28 | -0.41 | -46.4% | 162.00 | -5.6% | -1.9% | -5.4% | -6.8% | -6.6% | -7.7% | — |
| Nov 2, 2023 | AMC | -0.05 | -0.06 | -20.0% | 422.25 | -14.4% | -13.2% | -22.4% | -19.1% | -24.7% | -30.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4 | JP Morgan | Downgrade | Neutral → Underweight | $21 | $29.58 | $27.58 | -6.8% | -8.9% | — | — | — | — |
| Apr 2 | Benchmark | Maintains | Buy → Buy | — | $9.75 | $9.32 | -4.4% | +10.2% | +43.2% | +70.2% | +89.4% | +103.5% |
| Mar 3 | Citigroup | Maintains | Neutral → Neutral | — | $15.39 | $15.22 | -1.1% | -7.8% | +13.5% | +7.9% | -2.8% | -2.5% |
| Feb 27 | Barclays | Maintains | Underweight → Underweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +3.5% | -4.6% | +17.4% | +11.7% |
| Feb 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +3.5% | -4.6% | +17.4% | +11.7% |
| Nov 6 | Barclays | Maintains | Underweight → Underweight | — | $18.84 | $18.43 | -2.2% | -7.5% | -11.5% | -12.5% | -17.9% | -16.7% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.11 | $18.66 | +3.0% | +4.0% | -3.8% | -7.9% | -8.9% | -14.6% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.00 | $28.00 | +0.0% | -5.4% | -2.7% | -8.9% | -15.5% | -20.4% |
| Aug 20 | Bernstein | Downgrade | Outperform → Market Perform | — | $31.25 | $29.75 | -4.8% | -3.2% | -1.6% | +6.4% | +10.4% | -1.6% |
| Aug 15 | Jefferies | Maintains | Hold → Hold | — | $26.50 | $26.50 | +0.0% | +4.7% | +16.0% | +17.9% | +14.2% | +16.0% |
Recent Filings
8-K · 5.02
!!! Very High
agilon health, inc. -- 8-K 5.02: Executive Change
Agilon Health (AGL) appointed O'Rourke as Chief Executive Officer and President effective May 7, 2026, signaling leadership transition that investors should monitor for strategic direction changes.
Apr 27
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
AGL shareholders approved charter amendments at a special meeting, potentially altering governance structure or operational authority, which could affect future decision-making flexibility and shareholder rights.
Mar 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AGL is executing a reverse stock split, which consolidates shares but doesn't increase intrinsic value—investors should watch for post-split price momentum and whether this signals financial distress or restructuring needs.
Mar 18
8-K · 7.01
! Medium
agilon health, inc. -- 8-K 7.01: Regulation FD Disclosure
Agilon Health disclosed its Q4 2025 and full-year financial results through an investor presentation, providing shareholders with updated performance metrics and operational guidance.
Feb 25
8-K · 1.01
! Medium
agilon health, inc. -- 8-K 1.01: Financing / Debt Agreement
Agilon Health amended its debt agreement on February 12, 2026, modifying existing financing terms, though specific details about the amendment's financial impact require reviewing the full agreement.
Feb 12
Data updated apr 24, 2026 4:34pm
· Source: massive.com